SpyGlass Pharma Balance Sheet
SpyGlass Pharma's total assets for Q2 2026 were $243.43M, a decrease of -5.79% from the previous quarter. SGP total liabilities were $11.07M for the fiscal quarter, a 33.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
